These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11778975)

  • 21. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and tolerability of vinorelbine in the cancer therapy.
    Galano G; Caputo M; Tecce MF; Capasso A
    Curr Drug Saf; 2011 Jul; 6(3):185-93. PubMed ID: 22122393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients.
    Sorraritchingchai S; Thongprasert S; Charoentum C; Chewasakulyong B; Moonprakan S
    J Med Assoc Thai; 2004 Apr; 87(4):367-71. PubMed ID: 15217171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
    Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
    J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
    Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN; Yu QZ
    Respiration; 2008; 75(4):380-5. PubMed ID: 17851225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe neurotoxicity from vinorelbine-paclitaxel combinations.
    Parimoo D; Jeffers S; Muggia FM
    J Natl Cancer Inst; 1996 Aug; 88(15):1079-80. PubMed ID: 8683640
    [No Abstract]   [Full Text] [Related]  

  • 29. Docetaxel and non small-cell lung cancer: new indication. One of several non curative chemotherapies.
    Prescrire Int; 2001 Apr; 10(52):43-5. PubMed ID: 11718157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies].
    Niitani H
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1495-507. PubMed ID: 10500542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New chemotherapeutic agents in non-small-cell lung cancer.
    Feigal EG; Christian M; Cheson B; Grever M; Friedman MA
    Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Fossella FV; DeVore R; Kerr RN; Crawford J; Natale RR; Dunphy F; Kalman L; Miller V; Lee JS; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
    J Clin Oncol; 2000 Jun; 18(12):2354-62. PubMed ID: 10856094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-lasting response to vinorelbine in unresectable non-small cell lung carcinoma: a case with concomitant good quality of life.
    Seminara P; Lucá F; Gualdi G; Donato V; Accettura C; Peverini P; Franchi F
    Am J Med Sci; 1998 Dec; 316(6):398-400. PubMed ID: 9856695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinorelbine chemotherapy in non small cell lung cancer: experience in elderly patients.
    Tononi A; Panzini I; Oliverio G; Pasquini E; Gianni L; Nicolini M; Ravaioli A
    J Chemother; 1997 Aug; 9(4):304-8. PubMed ID: 9269613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term cure of a non-small-cell lung cancer treated by monochemotherapy.
    Jacoulet P; Maheu MF; Loire R; Saugier B; DePierre A
    Am J Clin Oncol; 1996 Jun; 19(3):260-2. PubMed ID: 8638537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature.
    Devlin JG; Langer CJ
    Clin Lung Cancer; 2007 Mar; 8(5):319-26. PubMed ID: 17562231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine: an update and review of activity.
    Johnson SA
    Clin Oncol (R Coll Radiol); 1996; 8(6):353-7. PubMed ID: 8973849
    [No Abstract]   [Full Text] [Related]  

  • 40. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.